Proto Labs, Inc. — 2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. This is an annual filing; the supplied text does not provide standalone fourth-quarter results. Proto Labs is a digital manufacturer of custom parts, using injection molding, CNC machining, 3D printing and sheet metal fabrication, supplemented by a global manufacturing-partner network.
Financial performance
| Metric | 2023 | 2022 |
|---|---|---|
| Revenue | $503.9 million | $488.4 million |
| Gross profit / margin | $222.0 million / 44.1% | $215.5 million / 44.1% |
| Operating income (loss) | $28.2 million | ($98.0 million) |
| Net income (loss) | $17.2 million; $0.66 diluted EPS | ($103.5 million); ($3.77) diluted EPS |
| Cash from operations | $73.3 million | $62.1 million |
| Capital expenditures | $28.1 million | $21.7 million |
Revenue rose 3.2%. CNC Machining increased 5.2%, 3D Printing 6.7% and Injection Molding 1.7%; Sheet Metal declined 15.2%. U.S. revenue grew 2.4% and Europe grew 15.4%. Japan revenue ended as the company completed its exit from that market in December 2023. Gross margin was unchanged year over year.
Operating results improved substantially from 2022, principally because 2022 included a $118.0 million Europe goodwill impairment. The company recorded no goodwill impairment in 2023. Its 2023 effective tax rate was 38.4%, compared with negative 5.7% in 2022.
Cash, liquidity and obligations
- Year-end cash and cash equivalents were $83.8 million, up from $56.6 million; short- and long-term marketable securities totaled $27.0 million. Management said cash and operating cash flow should meet anticipated requirements for at least 12 months.
- The company reported no financing arrangements. Year-end liabilities included $5.5 million of operating and finance lease obligations; it reported no conventional debt balance.
- Financing cash outflow was $41.9 million, primarily reflecting $44.0 million of share repurchases. The repurchase authorization had $88.4 million remaining at year-end.
- Cash held by foreign subsidiaries was $18.1 million; management intends to reinvest those funds outside the U.S.
Changes, outlook and risks
- Unique customer contacts declined 5.1% to 53,464, even as revenue grew. Management attributed the divergence partly to larger orders and higher average order values in the Protolabs Network.
- The company launched its integrated CNC offering in the U.S. in early 2023 after its European launch in 2022, and rebranded Hubs as the Protolabs Network by Hubs in January 2024.
- Management expects continued investment in technology, personnel and manufacturing capacity; it anticipates operating expenses and cost of revenue to rise in absolute dollars. It provided no quantified revenue or earnings guidance in the supplied filing text.
- Japan closure costs were $0.2 million in 2023, down from $6.9 million in 2022. The Japan exit also generated a $3.9 million foreign-currency translation loss recorded in 2023.
- Key risks include competitive and pricing pressure, uncertain demand and global economic conditions, execution of technology and network integration, manufacturing or IT disruption, cybersecurity and protection of customer designs, foreign-exchange exposure, supply-chain constraints, and attracting and retaining employees. The company does not hedge foreign-currency exposure and said a hypothetical 10% adverse currency move could materially affect operating results.
- Management reported effective disclosure controls and internal control over financial reporting; the auditor gave unqualified opinions on the financial statements and internal controls. The filing identifies revenue recognized over time as a critical audit matter because it depends on estimates of production progress and completion time.
Important facts for investors to verify
- Assess whether revenue growth and the higher Network order values can persist despite fewer customer contacts, and examine the product-line and regional trends.
- Separate recurring operating improvement from the comparison benefit of the prior-year goodwill impairment; review Europe’s ongoing segment losses and the assumptions behind goodwill valuations.
- Verify cash generation against planned capital spending, share repurchases and continued investment needs; consider the repurchase pace and remaining authorization.
- Review working-capital and revenue-recognition estimates, including $10.1 million of unbilled receivables at year-end, and the sensitivity of reported revenue to production-time estimates.
- Monitor currency effects, tax uncertainties, cybersecurity exposure and operational risks associated with facilities and manufacturing partners. The filing states that no litigation was expected to have a material adverse effect.